Multiple injections per injection episode: High-risk injection practice among people who injected pills during the 2015 HIV outbreak in Indiana.

Autor: Broz D; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: dbroz@cdc.gov., Zibbell J; Division of Viral Hepatitis, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States., Foote C; Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States., Roseberry JC; Indiana State Department of Health, Indianapolis, IN, United States., Patel MR; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States., Conrad C; Indiana State Department of Health, Indianapolis, IN, United States., Chapman E; Indiana State Department of Health, Indianapolis, IN, United States., Peters PJ; Division of HIV/AIDS Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, United States., Needle R; Division of Global HIV & TB, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States., McAlister C; Indiana University-Purdue University Indianapolis, Indianapolis, IN, United States., Duwve JM; Indiana State Department of Health, Indianapolis, IN, United States; Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN, United States.
Jazyk: angličtina
Zdroj: The International journal on drug policy [Int J Drug Policy] 2018 Feb; Vol. 52, pp. 97-101. Date of Electronic Publication: 2017 Dec 24.
DOI: 10.1016/j.drugpo.2017.12.003
Abstrakt: Background: Misuse of prescription opioid analgesics (POA) has increased dramatically in the US, particularly in non-urban areas. We examined injection practices among persons who inject POA in a rural area that experienced a large HIV outbreak in 2015.
Methods: Between August-September 2015, 25 persons who injected drugs within the past 12 months were recruited in Scott County, Indiana for a qualitative study. Data from in-depth, semi-structured interviews were analyzed.
Results: All 25 participants were non-Hispanic white and the median age was 33 years (range: 19-57). All had ever injected extended-release oxymorphone (Opana ® ER) and most (n=20) described preparing Opana ® ER for multiple injections per injection episode (MIPIE). MIPIE comprised 2-4 injections during an injection episode resulting from needing >1mL water to prepare Opana ® ER solution using 1mL syringes and the frequent use of "rinse shots." MIPIE occurred up to 10 times/day (totaling 35 injections/day), often in the context of sharing drug and injection equipment.
Conclusions: We describe a high-risk injection practice that may have contributed to the rapid spread of HIV in this community. Efforts to prevent bloodborne infections among people who inject POA need to assess for MIPIE so that provision of sterile injection equipment and safer injection education addresses the MIPIE risk environment.
(Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: